Silk Road Medical Inc
NASDAQ:SILK
Silk Road Medical Inc
Revenue
Silk Road Medical Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Silk Road Medical Inc
NASDAQ:SILK
|
Revenue
$177.1m
|
CAGR 3-Years
33%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
Haemonetics Corp
NYSE:HAE
|
Revenue
$1.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Cooper Companies Inc
NYSE:COO
|
Revenue
$3.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Revenue
$4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
0%
|
CAGR 10-Years
3%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Revenue
$3.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
19%
|
See Also
What is Silk Road Medical Inc's Revenue?
Revenue
177.1m
USD
Based on the financial report for Dec 31, 2023, Silk Road Medical Inc's Revenue amounts to 177.1m USD.
What is Silk Road Medical Inc's Revenue growth rate?
Revenue CAGR 5Y
39%
Over the last year, the Revenue growth was 28%. The average annual Revenue growth rates for Silk Road Medical Inc have been 33% over the past three years , 39% over the past five years .